Could one pill a day keep the transplant safe?
NCT ID NCT06354179
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether taking immunosuppressant drugs just once daily after a liver transplant is as safe and effective as the standard twice-daily schedule. The goal is to make it easier for patients to stick with their lifelong medication, which could improve their quality of life. About 162 adult liver transplant recipients will be followed for one year to compare rejection rates, adherence, and side effects between the two dosing strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tacrolimus and mycophenolate mofetil (immunosuppressants)
- What this could lead to
- If successful, this could simplify lifelong medication schedules for liver transplant patients, making it easier to stick to treatment and potentially improving quality of life.
- What could go wrong
- This is a Phase 4 study with 162 participants, so results may not apply to all patients. Simplifying dosing might not improve adherence or could slightly increase rejection risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOSUPPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHP
RECRUITINGMarseille, 13000, France
-
Beaujon hospital - APHP
RECRUITINGClichy, 92110, France
-
Bordeaux university hospital
RECRUITINGPessac, 33604, France
-
CHU de Besançon - Hôpital Jean Minjoz
RECRUITINGBesançon, 25000, France
-
CHU de Dijon Bourgogne
RECRUITINGDijon, 21000, France
-
CHu de Grenoble
NOT_YET_RECRUITINGGrenoble, 38043, France
-
Lille university hospital
RECRUITINGLille, 59000, France
-
Limoges university hospital
RECRUITINGLimoges, 87042, France
-
Lyon university hospital
RECRUITINGLyon, 69000, France
-
Montpellier university hospital
RECRUITINGMontpellier, 34000, France
-
Nice university hospital
RECRUITINGNice, 06202, France
-
Paul Brousse Hospital - APHP
RECRUITINGVillejuif, 94800, France
-
Pitie Salpetriere hospital - APHP
RECRUITINGParis, 75013, France
-
Poitiers university hospital
RECRUITINGPoitiers, 86000, France
-
Rennes university hospital
RECRUITINGRennes, 35033, France
-
Strasbourg university hospital
RECRUITINGStrasbourg, 67000, France
-
Toulouse university hospital
RECRUITINGToulouse, 31000, France
-
Tours university Hospital
RECRUITINGTours, 37000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo shield young hearts from transplant complications?
- A new Anti-Rejection strategy may spare kidney function after liver transplant
- Can a cell test free liver transplant patients from lifelong drugs?
- Smartphone messages may boost medication adherence after liver transplant
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
- Blood type no barrier? study tests liver transplant success across ABO barriers